LOGIN OR REGISTER
Course Library

Case Challenges in Chronic Urticaria: Optimizing Patient Assessment & Management

Allergy/ Immunology
Curriculum:
Case Challenges in Chronic Urticaria: Optimizing Patient Assessment & Management
Credits:
1.25 AMA PRA Category 1 Credit(s) ™
Launch Date:
November 20, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Allergy/immunology, dermatology, and primary care physicians, nurse practitioners, and physician assistants

Relevant Terms:

Chronic urticaria

Allen P. Kaplan, MD

Allen P. Kaplan, MD
Clinical Professor of Medicine
Department of Medicine
Medical University of South Carolina
Charleston, South Carolina

Allen P. Kaplan, MD, is clinical professor of medicine at the Medical University of South Carolina in Charleston, South Carolina. Dr. Kaplan is a graduate of Columbia University and Downstate Medical School in Brooklyn, New York, where he received a doctorate of medicine (summa cum laude). He completed his specialty training in allergy and clinical immunology at Harvard Medical School in Boston, Massachusetts, and his rheumatology training at the National Institutes of Health in Bethesda, Maryland. Subsequently, he became director of allergic diseases at the National Institutes of Health and then chairman of the Department of Medicine and director of allergic diseases at the State University of New York at Stony Brook. Dr. Kaplan is board certified in internal medicine, allergy and clinical immunology, rheumatology, and diagnostic laboratory immunology.

Dr. Kaplan is past president of the World Allergy Organization (2000–2003); the American Academy of Allergy, Asthma & Immunology; and the Clinical Immunology Society. He is also a fellow of the American Academy of Allergy Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the American College of Physicians.

Dr. Kaplan has authored more than 300 articles, monographs, and editorials, and he edited the textbook Allergy, which is used in training programs throughout the world. In addition, he co-edited the textbook Urticaria and Angioedema and the recently published two-volume textbook Allergy and Allergic Diseases. Dr. Kaplan's research interests focus on inflammatory mechanisms of allergic disease. He is a world-renowned authority on the mechanisms and treatment of urticaria and angioedema.

Allen P. Kaplan, MD

Allen P. Kaplan, MD
Clinical Professor of Medicine
Department of Medicine
Medical University of South Carolina
Charleston, South Carolina

Allen P. Kaplan, MD, is clinical professor of medicine at the Medical University of South Carolina in Charleston, South Carolina. Dr. Kaplan is a graduate of Columbia University and Downstate Medical School in Brooklyn, New York, where he received a doctorate of medicine (summa cum laude). He completed his specialty training in allergy and clinical immunology at Harvard Medical School in Boston, Massachusetts, and his rheumatology training at the National Institutes of Health in Bethesda, Maryland. Subsequently, he became director of allergic diseases at the National Institutes of Health and then chairman of the Department of Medicine and director of allergic diseases at the State University of New York at Stony Brook. Dr. Kaplan is board certified in internal medicine, allergy and clinical immunology, rheumatology, and diagnostic laboratory immunology.

Dr. Kaplan is past president of the World Allergy Organization (2000–2003); the American Academy of Allergy, Asthma & Immunology; and the Clinical Immunology Society. He is also a fellow of the American Academy of Allergy Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the American College of Physicians.

Dr. Kaplan has authored more than 300 articles, monographs, and editorials, and he edited the textbook Allergy, which is used in training programs throughout the world. In addition, he co-edited the textbook Urticaria and Angioedema and the recently published two-volume textbook Allergy and Allergic Diseases. Dr. Kaplan's research interests focus on inflammatory mechanisms of allergic disease. He is a world-renowned authority on the mechanisms and treatment of urticaria and angioedema.
1. Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic idiopathic urticaria (CIU) taking into account the potential differential diagnosis
2. Incorporate into practice evidence-based treatment options and guidelines for managing CIU that maximize efficacy, minimize adverse effects, and take into account patient quality of life

PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Allen P. Kaplan, MD, has affiliations with CSL Behring, Dyax, Genentech, and Sanofi-Aventis (Advisory Boards).
RMEI, LLC
  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
  • Boris Rozenfeld, MD, has no affiliations with commercial interests to disclose.
  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Amy Reeve has no affiliations with commercial interests relative to the content to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
 
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
 
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Estimated time to complete: 1.25 hours
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.

COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Genentech.

HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.25 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
 
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the self-assessment to receive credit for this activity. All other participants who successfully complete the self-assessment and evaluation will receive a certificate of participation.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above		 Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above



 

Schedule an event with a Standardized Patient
×